← Back to patent-cliff list
薄荷脑/水杨酸甲酯
Tier C — Watch / tradeMenthol/Methyl Salicylate
久光制药株式会社
Originator
2008
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：TRPM8
Brand：Salonpas
Indications (approved)：疼痛
Regional status
US
批准上市
2008-02-20
EU
-
China
批准上市
2009-01-04
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Menthol/Methyl Salicylate?
Approved indications include: 疼痛.
When does the Menthol/Methyl Salicylate patent expire?
No public expiry year is available for Menthol/Methyl Salicylate yet; this page updates once verified.
How do I get a quote for Menthol/Methyl Salicylate intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-24